Apollo-Backed Novolex to Buy Pactiv Evergreen for $3.22 Billion

Dow Jones
2024-12-09
 

By Colin Kellaher

 

Pactiv Evergreen has struck a deal to be acquired by fellow packaging company Novolex, majority owned by Apollo Global Management, for about $3.22 billion.

The companies Monday said Novolex will pay $18 a share in cash for Pactiv, a nearly 23% premium to Friday's closing price of $14.66 for the Lake Forest, Ill., company and some 32% above the company's closing price on Dec. 2, before published reports said Apollo was exploring a takeover.

New York buyout firm Apollo has been the majority shareholder of Novolex since 2022.

Pactiv and Novolex said the deal, valued at $6.7 billion including debt, is slated to close in mid-2025.

The companies said Canadian pension giant Canada Pension Plan Investment Board will contribute about $1 billion to the deal and will become a significant minority shareholder in the combined company.

Trading in Pactiv shares was halted premarket on Monday.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

December 09, 2024 08:24 ET (13:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10